[ET Net News Agency, 29 April 2025] REMEGEN (09995) fell 10.3% to HK$37.15.
It hits an intra-day low of HK$37.05, and an intra-day high of HK$43.35. The total
shares traded was 20.28 million, with a value of HK$789.48m. The active buy/sell ratio is
41:59, with net selling turnover of HK$138.82m. CHINA INV INFO accounts for greatest net
responsive buying turnover of HK$51.07m, with volume weighted average price of HK$38.86.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$17.65m,
with volume weighted average price of HK$38.398. The stock has fallen a combined 14.5%
over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 37.150 % Chg -10.27%
High 43.350 Low 37.050
Shares Tr 20.28m Turnover 789.48m
10-D SMA 36.630 %H.V 131.044
20-D SMA 31.105 VWAP 38.938
50-D SMA 23.130 RSI14 62.674
----------------------------------
Status: Active buy/sell ratio is 41:59, with net selling turnover of HK$138.82m, falling a
combined 14.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
REMEGEN (09995) 37.15 -10.27
INNOVENT BIO (01801) 53.45 -1.38
EVEREST MED-B (01952) 49.60 +11.21
XTALPI (02228) 5.01 -1.57
WUXI BIO (02269) 23.00 +0.66
WUXI APPTEC (02359) 60.35 +3.69
BEIGENE (06160) 148.90 +1.50
SKB BIO-B (06990) 331.40 +9.59
ZAI LAB (09688) 24.55 -0.61
AKESO (09926) 86.90 -0.34
---------------------------------------------
(ed)